Home Home Home Inbox Home Search

Event

Rationale and Design of TRACE: A Double-Blind, Placebo-Controlled Phase 4 Study in Pulmonary Arterial Hypertension to Assess the Effect of Selexipag on Physical Activity, Patient-Reported Symptoms and Their Impact, in Daily Life [Board No. P171]

Location: Board no. P171
Session Type: Thematic Poster Session
Tuesday
May
22
11:15 AM
1:00 PM
Home Home Home Inbox Home Search